Role of proteoglycans in the regulation of the skeletal muscle fibrotic response

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The FEBS Journal

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/febs.12278PMID 23560928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fell‐Muir lecture: connective tissue growth factor (CCN2) – a pernicious and pleiotropic player in the development of kidney fibrosis

  2013cited by this paper
• Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles

  2012cited by this paper
• PAI-1–regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy

  2012cited by this paper
• Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease

  2011cited by this paper
• Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF‐β1 blocker

  2011cited by this paper
• Aberrant repair and fibrosis development in skeletal muscle

  2011cited by this paper
• CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy

  2011cited by this paper
• Structure and function of the skeletal muscle extracellular matrix

  2011cited by this paper
• Decorin Interacts with Connective Tissue Growth Factor (CTGF)/CCN2 by LRR12 Inhibiting Its Biological Activity*

  2011cited by this paper
• Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.

  2011cited by this paper
• The Internal Region Leucine-rich Repeat 6 of Decorin Interacts with Low Density Lipoprotein Receptor-related Protein-1, Modulates Transforming Growth Factor (TGF)-β-dependent Signaling, and Inhibits TGF-β-dependent Fibrotic Response in Skeletal Muscles*

  2011cited by this paper
• CCN2/decorin interactions: a novel approach to combating fibrosis?

  2011cited by this paper
• Regulation and dysregulation of fibrosis in skeletal muscle.

  2010cited by this paper
• Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting

  2010cited by this paper
• Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2)

  2010cited by this paper
• Proteoglycans in health and disease: emerging concepts and future directions

  2010cited by this paper
• Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice

  2010cited by this paper
• Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.

  2010cited by this paper
• Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans

  2010cited by this paper
• Connective tissue growth factor: Context‐dependent functions and mechanisms of regulation

  2009cited by this paper
• Matrix Metalloproteinase-2-deficient Fibroblasts Exhibit an Alteration in the Fibrotic Response to Connective Tissue Growth Factor/CCN2 because of an Increase in the Levels of Endogenous Fibronectin*

  2009cited by this paper
• TGF-beta and fibrosis in different organs - molecular pathway imprints.

  2009cited by this paper
• Functions and mechanisms of action of CCN matricellular proteins.

  2009cited by this paper
• Renin-angiotensin system in the pathogenesis of liver fibrosis.

  2009cited by this paper
• Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma.

  2009cited by this paper
• Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.

  2008cited by this paper
• Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway.

  2008cited by this paper
• Glypicans

  2008cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.

  2008cited by this paper
• Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation

  2008cited by this paper
• Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy.

  2008cited by this paper
• Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo

  2008cited by this paper
• Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy.

  2008cited by this paper
• Skeletal muscle repair and regeneration

  2008cited by this paper
• Decorin gene transfer promotes muscle cell differentiation and muscle regeneration.

  2007cited by this paper
• Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis.

  2007cited by this paper
• Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin.

  2007cited by this paper
• A Novel Modulatory Mechanism of Transforming Growth Factor-β Signaling through Decorin and LRP-1*

  2007cited by this paper
• Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-β and CTGF/CCN2

  2007cited by this paper
• [Cellular and molecular mechanisms of fibrosis].

  2006cited by this paper
• Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease

  2006cited by this paper
• Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.

  2006cited by this paper
• All in the CCN family: essential matricellular signaling modulators emerge from the bunker

  2006cited by this paper
• Decorin binds myostatin and modulates its activity to muscle cells.

  2006cited by this paper
• Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.

  2006cited by this paper
• Heparan sulfates in skeletal muscle development and physiology

  2006cited by this paper
• The Low Density Lipoprotein Receptor-related Protein Functions as an Endocytic Receptor for Decorin*

  2006cited by this paper
• Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats

  2006cited by this paper
• Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-κB-induced CCAAT/enhancer-binding protein δ in mouse macrophages

  2006cited by this paper
• Decorin and biglycan expression is differentially altered in several muscular dystrophies.

  2005cited by this paper
• Cell surface and gene expression regulation molecules in dystrophinopathy: mdx vs. Duchenne.

  2005cited by this paper
• Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA.

  2005cited by this paper
• Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice

  2005cited by this paper
• Postnatal changes in sarcolemmal organization in the mdx mouse.

  2005cited by this paper
• Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis.

  2004cited by this paper
• Hypoxic induction of Ctgf is directly mediated by Hif-1.

  2004cited by this paper
• Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.

  2004cited by this paper
• Localization and early time course of TGF‐β1 mRNA expression in dystrophic muscle

  2004cited by this paper
• Profibrotic Effects of Endothelin-1 via the ETA Receptor in Cultured Human Cardiac Fibroblasts

  2004cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice.

  2003cited by this paper
• Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells.

  2003cited by this paper
• Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis

  2003cited by this paper
• The Low Density Lipoprotein Receptor-related Protein Complexes with Cell Surface Heparan Sulfate Proteoglycans to Regulate Proteoglycan-mediated Lipoprotein Catabolism*

  2003cited by this paper
• Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy

  2002cited by this paper
• Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy.

  2002cited by this paper
• Matricellular proteins: extracellular modulators of cell function.

  2002cited by this paper
• Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

  2002cited by this paper
• Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-β Superfamily

  2001cited by this paper
• The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration *

  2001cited by this paper
• Antisense Inhibition of Decorin Expression in Myoblasts Decreases Cell Responsiveness to Transforming Growth Factor β and Accelerates Skeletal Muscle Differentiation*

  2001cited by this paper
• Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.

  2001cited by this paper
• Impact of prednisone on TGF‐β1 and collagen in diaphragm muscle from mdx mice

  2001cited by this paper
• The Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Is a Receptor for Connective Tissue Growth Factor*

  2001cited by this paper
• Elevated plasma levels of transforming growth factor β1 in patients with muscular dystrophy

  2000cited by this paper
• The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle

  2000cited by this paper
• How cells read TGF-beta signals.

  2000cited by this paper
• Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle.

  2000cited by this paper
• How cells read TGF-β signals

  2000cited by this paper
• The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family.

  1999cited by this paper
• The Biology of the Small Leucine-rich Proteoglycans

  1999cited by this paper
• Transforming growth factor‐β2 is elevated in skeletal muscle disorders

  1999cited by this paper
• Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis.

  1999cited by this paper
• Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies.

  1999cited by this paper
• Functions of cell surface heparan sulfate proteoglycans.

  1999cited by this paper
• Expression of connective tissue growth factor in experimental rat and human liver fibrosis

  1999cited by this paper
• Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis.

  1998cited by this paper
• Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis.

  1998cited by this paper
• Expression of connective tissue growth factor in human renal fibrosis.

  1998cited by this paper
• Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen.

  1998cited by this paper
• Human connective tissue growth factor is expressed in advanced atherosclerotic lesions.

  1997cited by this paper
• The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.

  1997cited by this paper
• Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.

  1996cited by this paper
• Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

  1994cited by this paper
• The proteoglycan decorin is synthesized and secreted by differentiated myotubes.

  1991cited by this paper
• Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.

  1991cited by this paper
• Hormones, growth factors, and myogenic differentiation.

  1991cited by this paper
• Membrane binding characteristics of two forms of transforming growth factor-beta.

  1987cited by this paper
• Type beta transforming growth factor is an inhibitor of myogenic differentiation.

  1986cited by this paper

• The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice

  2025cites this paper
• Differential Fibrotic Response of Muscle Fibroblasts, Myoblasts, and Myotubes to Cholic and Deoxycholic Acids.

  2023cites this paper
• RNA sequencing analysis revealed differentially expressed genes and their functional annotation in porcine longissimus dorsi muscle affected by dietary lysine restriction

  2023cites this paper
• Alignment, cross-linking, and beyond: A collagen architect's guide to the skeletal muscle extracellular matrix.

  2023cites this paper
• Acellular collagen-glycosaminoglycan matrix promotes functional recovery in a rat model of volumetric muscle loss.

  2023cites this paper
• Exercise builds the scaffold of life: muscle extracellular matrix biomarker responses to physical activity, inactivity, and aging

  2022cites this paper
• Effects of paeonol on proliferation and collagen synthesis of rat cardiac fibroblasts induced by aldosterone

  2021cites this paper
• Role of Matricellular CCN Proteins in Skeletal Muscle: Focus on CCN2/CTGF and Its Regulation by Vasoactive Peptides

  2021cites this paper
• Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2/CTGF)

  2021cites this paper
• Skeletal Muscle Extracellular Matrix – What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review

  2020influential citation
• Remodeling the Skeletal Muscle Extracellular Matrix in Older Age—Effects of Acute Exercise Stimuli on Gene Expression

  2020cites this paper
• Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-β signaling upregulates CCN2/CTGF expression specifically in muscle fibers.

  2020cites this paper
• Characterization of Wilms' Tumour 1 (Wt1) as a Biomarker for Fibrosis in Duchenne Muscular Dystrophy

  2019cites this paper
• Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.

  2019cites this paper
• Cartilage-like composition of keloid scar extracellular matrix suggests fibroblast mis-differentiation in disease

  2019cites this paper
• A porous collagen‐GAG scaffold promotes muscle regeneration following volumetric muscle loss injury

  2019cites this paper
• Contribution of extracellular matrix components to the stiffness of skeletal muscle contractures in patients with cerebral palsy

  2019cites this paper
• Regulation of fibrosis in muscular dystrophy.

  2018cites this paper
• Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.

  2018cites this paper
• The inhibition of CTGF/CCN2 activity improves muscle and locomotor function in a murine ALS model

  2018cites this paper
• Skeletal muscle fibrosis: an overview

  2018cites this paper
• ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers

  2017cites this paper
• The role of TGF‐β1 during skeletal muscle regeneration

  2017cites this paper
• The emerging role of skeletal muscle extracellular matrix remodelling in obesity and exercise

  2017cites this paper
• Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis

  2016cites this paper
• Roles of chondroitin sulfate proteoglycan 4 in fibrogenic/adipogenic differentiation in skeletal muscle tissues.

  2016cites this paper
• High Final Energy of Low‐Level Gallium Arsenide Laser Therapy Enhances Skeletal Muscle Recovery without a Positive Effect on Collagen Remodeling

  2015cites this paper
• CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.

  2015cites this paper
• Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease.

  2015cites this paper
• The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle

  2015cites this paper
• Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle

  2015cites this paper
• Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

  2014cites this paper
• Decorin differentially modulates the activity of insulin receptor isoform A ligands.

  2014cites this paper
• ACE2 Is Augmented in Dystrophic Skeletal Muscle and Plays a Role in Decreasing Associated Fibrosis

  2014cites this paper
• Role of CTGF and TNF on fibrosis in muscular dystrophy

  2014cites this paper
• Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle

  2014cites this paper
• Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy

  2014cites this paper
• Simultaneous Enantioseparation of Monosaccharides Derivatized with l-Tryptophan by Reversed Phase HPLC

  2014cites this paper
• CCN2: a novel, specific and valid target for anti-fibrotic drug intervention

  2013cites this paper